U.S. Military HIV Research Program | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Analytics & Tracking
Email & Communication
Keywords & Focus Areas
U.S. Military HIV Research Program
Overview
The U.S. Military HIV Research Program (MHRP) is a federally funded initiative established in 1986 to combat HIV infection among U.S. and allied military personnel. Operating under the Walter Reed Army Institute of Research, MHRP focuses on developing an HIV-1 vaccine, advancing prevention and treatment strategies, and conducting impactful research on HIV/AIDS.
MHRP's mission is to safeguard the health and readiness of U.S. service members while contributing to the global fight against HIV/AIDS. The program is known for its pioneering work, including the RV144 Thai trial, which was the first to show modest efficacy in an HIV vaccine study. MHRP engages in various research areas, including vaccine development, epidemiology, diagnostics, and therapeutics, and collaborates with organizations like the Henry M. Jackson Foundation and the U.S. National Institute of Allergy and Infectious Diseases. Its research benefits not only military personnel but also global communities affected by HIV.
Basic Information
| Industry | research |
|---|---|
| Founded | 1986 |
| Revenue | 29.4M |
| Headquarters | 503 Robert Grant Ave, Silver Spring, Maryland 20910, United States |
| Alexa Ranking | 131996 |
Contact Details
- Phone: +1 301-500-3600
- Website: hivresearch.org
- LinkedIn: linkedin.com/company/u-s-military-hiv-research-program
Key Focus Areas & Initiatives
- infectious disease research
- global health
- hiv diagnostics
- military health
- hiv cure research
- pepfar
- hiv vaccine research
- emerging infectious diseases
- epidemiology
- hiv research
- research services
- hiv acute infection studies
- hiv epidemiology in africa and asia
- acute hiv infection research
- epidemiological studies
- hiv epidemiology
- hiv immune response mechanisms
- hiv risk reduction
- injectable hiv countermeasures
- hiv vaccine safety
- hjf partnership
- injectable hiv prevention
- hiv risk assessment in high-risk populations
- research and development
- clinical trials
- global health collaboration
- hiv vaccine trial
- hiv risk assessment
- hiv blood safety
- bispecific monoclonal antibodies
- hiv epidemiology in resource-limited settings
- hiv vaccine efficacy
- hiv therapeutics development
- hiv immune response
- hiv community engagement
- hiv threat assessment
- hiv vaccine efficacy studies
- hiv vaccine adjuvants
- hiv research funding
- hiv research collaboration
- hiv vaccine efficacy in military
- healthcare
- hiv functional cure
- hiv funding
- services
- global health security
- functional cure
- hiv immune correlates
- hiv diagnostics innovation
- hiv therapeutics
- hiv adjuvants
- hiv prevention
- injectable countermeasures
- international research sites
- pepfar collaboration
- clinical research
- hiv vaccine development pipeline
- medical research
- hiv vaccine design
- acute hiv infection
- hiv transmission prevention
- hiv diagnostics development
- infectious disease diagnostics
- infectious disease countermeasures
- vaccine research
- hiv program expansion
- hiv prevention strategies
- b2b
- hiv monoclonal antibodies
- hiv vaccine development
- hiv immunology
- monoclonal antibodies
- hiv immunization
- hiv community programs
- u.s. military health
- wrair research
- hiv transmission prevention methods
- hiv blood transfusion safety
- research and development in the physical, engineering, and life sciences
- hiv clinical trials
- bispecific antibodies
- non-profit
- research & development
- health care
- health, wellness & fitness
- hospital & health care
- nonprofit organization management
Technologies Used
- Google Tag Manager
- Microsoft Office 365
- Mobile Friendly
- Nginx
- Outlook
- Varnish